McKesson Corporation Reports Q3 EPS of $1.12 vs. $1.11; Revenues $28.2 vs. $28.35B

McKesson Corporation MCK today reported that revenues for the third quarter ended December 31, 2010 were $28.2 billion. Third-quarter earnings per diluted share was 60 cents, which included a pre-tax Average Wholesale Price litigation charge of $189 million ($133 million after-tax or 52 cents per diluted share). Excluding the AWP litigation charge, third-quarter earnings per diluted share from continuing operations was $1.12, which included approximately 10 cents per diluted share of transaction expenses related to the acquisition of US Oncology. In the prior year's third quarter, earnings per diluted share was $1.19, which included the benefit of higher-margin distribution services revenues associated with the H1N1 flu virus.